Funded Tech Companies

Therapeutic Human Polyclonals

Therapeutic Human Polyclonals was a biopharmaceutical company, based in Sunnyvale. The company was acquired by Roche.

Company Overview

Company Name
Therapeutic Human Polyclonals
Company Status
Acquired or Merged
Funding Rounds
Total Funding

Contact Information

Mailing Address
1444 Floyd Drive
Sunnyvale, CA 94087
USA
Phone
Undisclosed
Email Address
Not Recorded

Company Background Information

Overview
THP is an emerging biotechnology company focused on research in the field of human antibody technologies. THP has developed a unique transgenic mammalian platform to create human antibodies. The technology will enable the generation of both monoclonal and polyclonal antibody therapeutics with enhanced efficacy.
Profile
Therapeutic Human Polyclonals LinkedIn Company Profile
Social Media
Therapeutic Human Polyclonals Company Twitter Account
Company News
Therapeutic Human Polyclonals News
Facebook
Therapeutic Human Polyclonals on Facebook
YouTube
Therapeutic Human Polyclonals on YouTube
Last Transaction
4/2/2007

Financing History

Date
Type
Amount
M&A
$56,500,000


Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Theranox | Therapixel

     

    Share this article

     


    About Our VC Transaction Database

    This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary